These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21659749)

  • 21. Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions.
    Tang AH; Brunn GJ; Cascalho M; Platt JL
    J Leukoc Biol; 2007 Aug; 82(2):282-5. PubMed ID: 17495051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
    Kumar V; Sharma A
    J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis.
    Weiss M; Moldawer LL; Schneider EM
    Blood; 1999 Jan; 93(2):425-39. PubMed ID: 9885204
    [No Abstract]   [Full Text] [Related]  

  • 25. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis.
    Castellheim A; Brekke OL; Espevik T; Harboe M; Mollnes TE
    Scand J Immunol; 2009 Jun; 69(6):479-91. PubMed ID: 19439008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Ninjurin1 to Toll-like receptor 4 signaling and systemic inflammation.
    Jennewein C; Sowa R; Faber AC; Dildey M; von Knethen A; Meybohm P; Scheller B; Dröse S; Zacharowski K
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):656-63. PubMed ID: 25860173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli-induced immune paralysis is not exacerbated during chronic filarial infection.
    Buerfent BC; Gondorf F; Wohlleber D; Schumak B; Hoerauf A; Hübner MP
    Immunology; 2015 May; 145(1):150-60. PubMed ID: 25521437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis].
    Aikawa N; Fujishima S
    Nihon Rinsho; 2004 Dec; 62(12):2173-6. PubMed ID: 15597781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The usage of therapeutic drugs and its valuation].
    Endo S; Sato N
    Nihon Rinsho; 2004 Dec; 62(12):2313-6. PubMed ID: 15597802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome.
    Xu PB; Lou JS; Ren Y; Miao CH; Deng XM
    J Infect; 2012 Nov; 65(5):380-91. PubMed ID: 22885911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epigenetic regulation in sepsis : current state of knowledge].
    Weiterer S; Uhle F; Siegler BH; Lichtenstern C; Bartkuhn M; Weigand MA
    Anaesthesist; 2015 Jan; 64(1):42-55. PubMed ID: 25471356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.
    Fry DE
    Am Surg; 2012 Jan; 78(1):1-8. PubMed ID: 22273282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roger C. Bone, MD and the evolving paradigms of sepsis.
    Balk R
    Contrib Microbiol; 2011; 17():1-11. PubMed ID: 21659744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis.
    Perl M; Chung CS; Garber M; Huang X; Ayala A
    Front Biosci; 2006 Jan; 11():272-99. PubMed ID: 16146731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Host inflammatory and anti-inflammatory response during sepsis].
    Adib-Conquy M; Cavaillon JM
    Pathol Biol (Paris); 2012 Oct; 60(5):306-13. PubMed ID: 22542429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The systemic pro-inflammatory response in sepsis.
    de Jong HK; van der Poll T; Wiersinga WJ
    J Innate Immun; 2010; 2(5):422-30. PubMed ID: 20530955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis.
    van der Poll T; Meijers JC
    J Innate Immun; 2010; 2(5):379-80. PubMed ID: 20606408
    [No Abstract]   [Full Text] [Related]  

  • 38. Sepsis syndromes: understanding the role of innate and acquired immunity.
    Oberholzer A; Oberholzer C; Moldawer LL
    Shock; 2001 Aug; 16(2):83-96. PubMed ID: 11508871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis-induced immunosuppression: from bad to worse.
    Reddy RC; Chen GH; Tekchandani PK; Standiford TJ
    Immunol Res; 2001; 24(3):273-87. PubMed ID: 11817325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of the immune response in severe sepsis.
    Pinsky MR
    Am J Med Sci; 2004 Oct; 328(4):220-9. PubMed ID: 15486537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.